Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism: A Danish nationwide cohort study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism : A Danish nationwide cohort study. / Nouhravesh, Nina; Strange, Jarl E.; Sindet-Pedersen, Caroline; Holt, Anders; Tønnesen, Jacob; Andersen, Camilla Fuchs; Nielsen, Sebastian K.; Grove, Erik L.; Nielsen, Dorte; Schou, Morten; Lamberts, Morten.
I: International Journal of Cardiology, Bind 406, 132001, 2024.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism
T2 - A Danish nationwide cohort study
AU - Nouhravesh, Nina
AU - Strange, Jarl E.
AU - Sindet-Pedersen, Caroline
AU - Holt, Anders
AU - Tønnesen, Jacob
AU - Andersen, Camilla Fuchs
AU - Nielsen, Sebastian K.
AU - Grove, Erik L.
AU - Nielsen, Dorte
AU - Schou, Morten
AU - Lamberts, Morten
N1 - Publisher Copyright: © 2024 The Authors
PY - 2024
Y1 - 2024
N2 - Background: Pulmonary embolism (PE) is described as a prognostic factor in patients with cancer however, the prognostic impact of PE remains unknown. This study investigated, the 1-year prognosis following PE in patients with breast-, gastrointestinal-, or lung cancer stratified by cancer status. Methods: All Danish patients with first-time PE from 2008 to 2018 were included. Cancer status was categorized as no cancer, history of cancer, non-active cancer and active cancer. Unadjusted and age-stratified 1-year risk of death was estimated using the Kaplan-Meier estimator. Cause of death was reported using the Aalen-Johansen method. Results: Of 35,679 patients with PE, 18% had a breast-, gastrointestinal-, or lung cancer. Patients with cancer were older compared with no cancer (69.8 years [IQR: 56.2–79.8]). One-year risk of death (95% confidence interval) for active breast-, gastrointestinal-, and lung cancer was 49.5% (44.0%–54.9%), 75.0% (72.5%–77.4%) and 80.1% (78.0%–82.3%) respectively, compared with 18.9% (18.4%–19.3%) for no cancer. Age-stratified analysis revealed no association with increasing age in non-active lung cancer and all active cancers. Further, non-cardiovascular death accounted for an increasing proportion by cancer status (no cancer < history of cancer < non-active cancer < active cancer). Conclusions: One-year risk of death was dependent on both cancer type and status; no association with age was found for patients with active cancers. Non-cardiovascular death was leading in non-active and active cancers. Thus, the occurrence of first-time PE could be regarded as a marker of cancer severity for patients with breast-, gastrointestinal-, and lung cancer.
AB - Background: Pulmonary embolism (PE) is described as a prognostic factor in patients with cancer however, the prognostic impact of PE remains unknown. This study investigated, the 1-year prognosis following PE in patients with breast-, gastrointestinal-, or lung cancer stratified by cancer status. Methods: All Danish patients with first-time PE from 2008 to 2018 were included. Cancer status was categorized as no cancer, history of cancer, non-active cancer and active cancer. Unadjusted and age-stratified 1-year risk of death was estimated using the Kaplan-Meier estimator. Cause of death was reported using the Aalen-Johansen method. Results: Of 35,679 patients with PE, 18% had a breast-, gastrointestinal-, or lung cancer. Patients with cancer were older compared with no cancer (69.8 years [IQR: 56.2–79.8]). One-year risk of death (95% confidence interval) for active breast-, gastrointestinal-, and lung cancer was 49.5% (44.0%–54.9%), 75.0% (72.5%–77.4%) and 80.1% (78.0%–82.3%) respectively, compared with 18.9% (18.4%–19.3%) for no cancer. Age-stratified analysis revealed no association with increasing age in non-active lung cancer and all active cancers. Further, non-cardiovascular death accounted for an increasing proportion by cancer status (no cancer < history of cancer < non-active cancer < active cancer). Conclusions: One-year risk of death was dependent on both cancer type and status; no association with age was found for patients with active cancers. Non-cardiovascular death was leading in non-active and active cancers. Thus, the occurrence of first-time PE could be regarded as a marker of cancer severity for patients with breast-, gastrointestinal-, and lung cancer.
KW - Breast cancer
KW - Cardio-oncology
KW - Gastrointestinal cancer
KW - Lung cancer
KW - Pulmonary embolism
U2 - 10.1016/j.ijcard.2024.132001
DO - 10.1016/j.ijcard.2024.132001
M3 - Journal article
C2 - 38561107
AN - SCOPUS:85189666922
VL - 406
JO - International Journal of Cardiology
JF - International Journal of Cardiology
SN - 0167-5273
M1 - 132001
ER -
ID: 391620564